FBXL19 and hepatocellular carcinoma: ROCs of FBXL19-AS1 in HCC, drawn to evaluate the diagnostic value, indicated that FBXL19-AS1 had moderate diagnostic ability to distinguish HCC patients from healthy people (AUC = 0.875, p < 0.001).